Extending and enhancing the Lives of Patients with Cancer

Our vision is to be the premier Cancer Bioenergetics Company designing drugs to attack the proteins and enzymes reconfigured and repurposed in cancer and responsible for the tumors metabolic processes. In addition to our drug currently in clinical trials, we expect to regularly add newly developed drug substances and drug products from our discovery engine optimized by indication, patient population, and dosage form. We believe that our drugs will be useful for the treatment of newly diagnosed patients, achieving important clinical responses in tumors that are difficult to treat with existing therapies, while also yielding substantially improved duration of such responses for many patients.